Author Interviews / 29.05.2024
DDW2024: SonarMD Program Reduced ER Visits and Health Care Costs for IBD Patients
MedicalResearch.com Interview with:
[caption id="attachment_61816" align="alignleft" width="125"]
Dr. Kosinski[/caption]
Dr. Larry Kosinski, MD
Gastroenterologist and SonarMD Founder & Board Member
MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by the IBD group of diseases?
Response: Affecting up to 70 million Americans, the U.S. spends $136 billion each year on digestive health as these conditions are complex to predict, treat and manage. Inflammatory Bowel Disease (IBD) includes people specifically diagnosed with either ulcerative colitis or Crohn’s disease, and these conditions require close monitoring to reduce the risk for complications that lead to lengthy hospital stays and significant medical spend. In addition to providing a holistic health program, the SonarMD digital platform risk stratifies patients and performs continuous symptom checks to identify deteriorating symptoms sooner and communicate changes to physicians, meaning that care teams can intervene faster to keep patients healthier and lower the overall cost of care.
The two large, longitudinal studies that we presented at Digestive Disease Week 2024 evaluated several major drivers of medical costs in people living with IBD and enrolled in the SonarMD end-to-end, digital care coordination program to determine if SonarMD’s program reduced healthcare utilization and concurrently produced better health outcomes. To assess this, we looked at Emergency Department visits and In-patient Admissions compared to risk-matched control groups.
Dr. Kosinski[/caption]
Dr. Larry Kosinski, MD
Gastroenterologist and SonarMD Founder & Board Member
MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by the IBD group of diseases?
Response: Affecting up to 70 million Americans, the U.S. spends $136 billion each year on digestive health as these conditions are complex to predict, treat and manage. Inflammatory Bowel Disease (IBD) includes people specifically diagnosed with either ulcerative colitis or Crohn’s disease, and these conditions require close monitoring to reduce the risk for complications that lead to lengthy hospital stays and significant medical spend. In addition to providing a holistic health program, the SonarMD digital platform risk stratifies patients and performs continuous symptom checks to identify deteriorating symptoms sooner and communicate changes to physicians, meaning that care teams can intervene faster to keep patients healthier and lower the overall cost of care.
The two large, longitudinal studies that we presented at Digestive Disease Week 2024 evaluated several major drivers of medical costs in people living with IBD and enrolled in the SonarMD end-to-end, digital care coordination program to determine if SonarMD’s program reduced healthcare utilization and concurrently produced better health outcomes. To assess this, we looked at Emergency Department visits and In-patient Admissions compared to risk-matched control groups.
Dr. Alexis[/caption]
Andrew F. Alexis, MD, MPH
Vice-Chair for Diversity and Inclusion
Department of Dermatology
Dermatologist
Center for Diverse Skin Complexions
Weill Cornell Medicine – NY
MedicalResearch.com: What are the main types of skin cancer? Is the incidence changing?
Response: The 3 main types of skin cancer are melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Skin cancer is the most common cancer in the United States1 and 1 in 5 Americans will develop skin cancer in their lifetime. (2)
The overall incidence has changed as follows:
• Melanoma: Rates doubled over past 30 years from 1982 to 2011.3 It differs by age group.
o Adolescents and adults age 30 and younger: incidence rate is declining
o Older age groups (e.g. 80 and older): incidence rate is increasing
• Squamous Cell Cancer:
o Incidence increased 263% between 1976-1984 and 2000-20104
• Basal Cell Cancer:
o Incidence increased 145% between 1976-1984 and 2000-20104
Dr. Parekh[/caption]
Ankit Parekh, PhD
Director of the Sleep And Circadian Analysis (SCAN) Group
Assistant Professor of Medicine
(Pulmonary, Critical Care and Sleep Medicine)
Icahn School of Medicine at Mount Sinai
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Sleep apnea is associated with incident cardiovascular disease, and is a common chronic condition affecting over a billion people worldwide. In diagnosing and treating sleep apnea, it is imperative to establish the type of sleep apnea—whether it is obstructive or central sleep apnea. The differential contribution of central vs. obstructive sleep apnea toward incidental cardiovascular disease in those with significant sleep apnea has not been well studied.
Our group has developed an automated algorithm that deduces on a breath-by-breath level whether reductions in airflow are predominantly due to obstructive or central phenomena. Our algorithm uses several features that are known to be key in distinguishing the type of events and derives a probability of obstruction across each “small” (reduced amplitude) breath. The breath-by-breath probability is then used to determine whether a patient’s burden of sleep apnea is predominantly obstructive or central.
In this work, we analyzed sleep study data from The Osteoporotic Fractures in Men (MrOS) cohort (N=2793) consisting of elderly men, across two visits separated on average by 6.5 years, and derived the probability of obstruction on a breath-by-breath level. The median probability of obstruction for each subject was computed and analyzed against outcomes of cardiovascular disease. We also assessed the stability of the metric in those without any prevalent cardiovascular disease. We find that median probability of obstruction was stable across the two visits, and those with any incident cardiovascular disease had a lower median probability of obstruction: patients with incident cardiovascular outcomes had a significant burden of sleep apnea that was predominantly “central” in nature.
Dr. Haigh[/caption]
Cathryn Haigh, Ph.D.
In recent years, our communities have faced unprecedented challenges to public health and hygiene, especially after the most recent global pandemic. Beyond the immediate crises, longstanding issues like poor dietary choices and the rising stress levels in people worldwide have further highlighted the critical need for robust health and hygiene practices.
These concerns, while global in scale, demand local solutions—initiatives that begin in our own neighborhoods. Promoting health and hygiene at a community level not only addresses these urgent issues but also sets the foundation for broader national change. This article offers ten tips for anyone eager to lead such transformative efforts within their community, underscoring that even the smallest steps can pave the way to significant health improvements for all.
Dr. Guasch-Ferré[/caption]
Marta Guasch-Ferré, PhD
Associate Professor and Deputy Head of Section, Section of Epidemiology
University of Copenhagen
Group Leader, Novo Nordisk Foundation Center for Basic Metabolic Research
Adjunct Associate Professor, Department of Nutrition
Harvard TH Chan School of Public Health
MedicalResearch.com: What is the background for this study?
Response: Olive oil is rich in monounsaturated fats and contains compounds with antioxidant activity that may play a protective role for the brain. Olive oil as part of a Mediterranean diet appears to have a beneficial effect against cognitive decline. Higher olive oil intake was previously associated with a lower risk of cardiovascular disease and mortality. But its association with dementia mortality was unknown.
Prof. Mainelis[/caption]
Gediminas "Gedi" Mainelis, Ph.D.
Professor, Department of Environmental Sciences
School of Environmental and Biological Sciences
Rutgers, The State University of New Jersey
MedicalResearch.com: What is the background for this study? What types of particles, ie where do they come from?
Response: This work is a continuation of my research on nanoparticles in consumer products. We have investigated and published on the release of particles from nano-enabled consumer products, such as cosmetic powders, various sprays and clothing.
In this project, we were interested in potential resuspension of particles once nano-enabled consumer sprays are used. The particles are added into consumer products to provide them certain desired properties, like antimicrobial protection, odor reduction or protection against UV (sunscreen). Once the products are used, the particles are released and we could be exposed to them.
Dr. Li Gan[/caption]
Dr. Li Gan PhD
Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases
Brain and Mind Research Institute
Weill Cornell Medical College
[caption id="attachment_61627" align="alignleft" width="150"]
Amy Kennalley[/caption]
Amy Kennalley, MBS
First Year Medical Student
Department of Medical Education
Geisinger Commonwealth School of Medicine
MedicalResearch.com: What is the background for this study
Response: The legalization of medical marijuana (MMJ) and the number of qualifying conditions are expanding across the USA, emphasizing the need to understand the implications of MMJ dispensary distribution for equitable access. Pennsylvania (PA) legalized MMJ in 2016, with the first dispensary opening its doors in 2018. The state currently recognizes 24 medical conditions for MMJ use, including six for which there is insufficient or no evidence for their efficacy as a treatment. Prior research suggests that there is a link between proximity to dispensaries and overall MMJ use. However, a gap exists in our understanding of how dispensary locations might be associated with the specific qualifying conditions for which individuals receive their certification.
In response to this knowledge gap, our study delved into the medical marijuana dispensary access in PA and explored associations with both MMJ certifications and the community demographics. Utilizing data from the Pennsylvania Department of Health, we investigated how proximity to MMJ dispensaries related to the proportion of individuals certified for MMJ use within a specific area or Zip Code Tabulation Area. Additionally, we analyzed the proportion of certifications for conditions with varying levels of evidence supporting the efficacy of MMJ.
This pioneering study represents the first of its kind in PA, shedding light on the association between MMJ dispensary locations and certifications. Likewise, it is the first in the US to investigate the link between dispensary locations and specific qualifying conditions. By examining these dynamics, we aim to contribute vital insights to inform policy and practice, ensuring equitable access to MMJ treatment for individuals with diverse medical needs.
Dr. Tesi[/caption]
MedicalResearch.com Interview with:
RJ Tesi M.D.
CEO and Founder of 